Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 2

Should a third party know your research submission to institutional ethics committee – a dilemma?

Pages
662–663
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article throws a highlight on this dilemma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Research studies are now a part of every student and teachers in a medical college and their aim can range from completion of thesis to need for promotion.
📊
Key Findings & Data:Irrespective of the purpose, studies, especially prospective types done on human or animals often require approval from institutional ethics committee and it’s considered today to be mandatory.
💡
Conclusion & Impact:This article throws a highlight on this dilemma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Research studies are now a part of every student and teachers in a medical college and their aim can range from completion of thesis to need for promotion. Irrespective of the purpose, studies, especially prospective types done on human or animals often require approval from institutional ethics committee and it’s considered today to be mandatory. However during the course of submission of research proposal, is it right for others to know your research? This article throws a highlight on this dilemma.

🔖

Cite This Article

Jain, A. K. C. (2022). Should a third party know your research submission to institutional ethics committee – a dilemma?. Medicine Science, Cilt: 10 - Sayı: 2, 662–663. https://ajindex.com/articles/579708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Shah PC, Panchasara AK, Barvaliya MJ, et al. A study of assessing errors and completeness of research application forms submitted to instituitional Ethics Committee (IEC) of a Tertiary Care Hospital. J Clin Diagn Res. 2016;10:10‐12. Davis S. Monitoring of approved studies: A difficult tightrope walks by Ethics Committees. Perspect Clin Res. 2018;9:91-4.